UPDATE 1-Orexigen buys U.S. obesity pill rights from Takeda, partners Valeant
March 15 (Reuters) - Orexigen Therapeutics Inc said it agreed to buy the U.S. rights to its flagship obesity drug from partner Takeda Pharmaceutical Co Ltd and will tap Canada's Valeant...
No comments:
Post a Comment